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Abstract: Nowadays, various types and forms of clinical biobanks have been gradually established worldwide, which
have become one of the important components and research platforms of life science and related disease researches in
the medical system. This article mainly introduces the construction, management and operation of clinical biobanks, and
discusses the medical ethics faced by it.
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1. Introduction
Clinical biological samples are of scarcity and
non-renewal, the research results and conclusions of
which accord with the actual situation of human
pathology, effectively reflect the characteristics of the
disease, and can provide reference to clinical diagnosis
and treatment. In addition, clinical biological samples
have become a valuable resource to explore the
pathogenesis of the disease, master the law of disease
development, develop medical means, and research and
develop pharmacy[1].
2. Establishment, operation and
management of clinical biobanks
The establishment, operation and management of
clinical biobanks should be scientific, systematic and
comprehensive. Clinical samples of patients to be
collected include body fluids, blood, pathological tissues,
nucleic acids and proteins. The following will introduce
several requirements for the establishment of
clinical biobanks should meet the following requirements:
1. In order to ensure the updating and replenishment of
samples, stable sample sources are needed. 2.
Standardized collection process of biological samples
and sound clinical diagnosis and treatment conditions are
needed to ensure the timeliness and reliability of samples.
3. Laboratory personnel are required to possess clinical
medical knowledge to perfectly take up this job. 4.
Perfect medical facilities and software systems for
sample information management are needed. 5. The
follow-up processing technology of the samples is
necessary to ensure that they can be used in the research
of cell biology and molecular biology.
The increasing sample amount is followed by
gradual increase of sample information, both of which
are under dynamic changes. Therefore, it is an important
process to establ ish a safe , re l iable , stable and
efficient biobank management system with complete
functions for collecting and inducing information
of biological samples, so as to ensure the establishment
and managemen t of biobanks . Reg i s t ra t i on of
the biological sample information consists of the
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following three aspects: first, the basic information
of biological samples, such as number, type, amount,
date, location, storage location, usage time, situation,
personnel, and research. Secondly, information of sample
patients, such as citizen information, medical history,
family genetic information, diagnosis and treatment
indicators and measures, and follow-up information.
Finally, the experimental results and feedback of data,
such as analysis, collection, follow-up, sample allocation
and cooperation of samples, correlation research, and
research topics, to reduce repetitive work.
In the application of samples, there should be
standard and perfect management measures for the
clinical biobanks to prevent the occurrence of
unexpected situations such as lost samples and pollution
on samples caused by improper management or practices.
In order to meet the needs of repeated use, samples
should be sub-packed to ensure their survival, and then a
scientific and reasonable storage system for biological
samples should be established, as well as the follow-up
processing and verification technologies, such as cell
separation, cell identification, cell detection and nucleic
acid extraction technologies. Through that, it can ensure
the quality of the extracted products to be provided to the
experimenters. Regular sampling inspection should be
carried out to the stored biological samples so as to
ensure their activity, reduce the loss and improve the
work efficiency, thus achieving the purpose of biological
research.
The clinical biological sample resources should be
carefully protected and rationally utilized, combining the
disease of patients, diagnosis and treatment results,
routine detection and treatment methods. Specifically
speaking, it is necessary to observe and study the
occurrence and development of diseases, and
comprehensively evaluate the different levels of organs,
tissues, cells and molecules; adopting new medical
technologies in difficult diagnosed cases is helpful to
improve medical quality and accumulate medical
experience. Moreover, a large number of confirmed
samples of single and multiple diseases are provided for
medical research and teaching, which can reduce
research time and is benefit to carry out targeted research
work.
3. The medical ethics faced by the
clinical biobanks
In the past, researchers often needed to select and
test clinical samples according to the research subject.
However, the collected samples were only used for
research. The collection and preservation of biological
samples ended along with the completion of the subject.
Both researchers and sample providers often treat the
remaining samples as medical waste after clinical
diagnosis and treatment. In the process of collecting
clinical cases and operation of biobanks, it is easy to
ignore the review and constraints of medical ethics[2].
During collecting samples and running and
managing biobanks, the medical ethics involved include
the following points: 1. Whether providers agrees to the
collection of samples and related information, and the
scope and specific contents agreed by providers; 2. When
samples are taken in the biobanks, whether the sample
providers have the right of personal ownership, the right
to be informed about the research, and whether the
research results and conclusions are fed back to
providers. 3. The direction of sample research,
researchers and research content should be clear and
whether providers still need to cooperate in the process
of research. 4. Whether sample providers can benefit and
how to benefit more patients. 5. Whether sample
providers will be affected by providing samples and
whether the samples will be used for commercial
purposes. 6. What measures can be taken to ensure the
privacy and safety of providers and samples. 7. How to
dispose and destruct samples after the research[3,4].
As a public resource for medical
research, biological samples inevitably involve interests.
Although the collection of biological samples is different
from the clinical research carried out in human body, its
essence is human body research and involves the
personal interests of the samples providers. Therefore,
the principles of medical ethics in clinical research also
apply to the ethical review of biobanks.
4. Ethical review points of
clinical biobanks
4.1 The benefits and risks of biobanks, and
the determination of the ownership
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of biological samples
The research results of biobanks have improved the
medical level of a certain disease, and promoted the
development of medicine, by adopting the group
research method instead of individual experiments. There
is a remarkable difference between in vitro study
of biological samples and direct interventional clinical
study of human body, and there is almost no damage to
sample providers. When samples and their information
are included in the biobanks, the individual attributes of
these samples are transformed into disease types or
group biological attributes of sample types to a certain
extent. Therefore, the individual samples become public
scientific research resources, thus achieving the sharing
of the individual interests of sample providers and the
common interests of society.
4.2 Protect the privacy of biological sample
providers and the safety of the samples
In the actual operation of biobanks, in order to
prevent the privacy of sample providers from being
disclosed, and ensure the objectivity and accuracy of the
research, the unique coded identification is often adopted
to encrypt the samples, and the anonymity is applied to
protect the privacy of sample providers, thus ensuring
that sample providers are not affected by the research[5].
At the same time, different levels of access rights
should be established so as to clarify the relevant
information of the visitors. When external or foreign
organizations are involved, corresponding protection
measures need to be formulated to prevent the
information of clinical biological samples and sample
providers from disclosure, which may cause loss of
disease information and ethnic heritage information.
4.3 Set the contents of the informed consent
of biobanks
The basic principles of informed consent are fully
informed, fully understanding, independently choosing,
personally deciding, etc., while the contents of which
include signed consent and oral consent. When designing
and defining the contents of the informed consent, it is
necessary to fully inform the functions of biobanks and
the obligations of the researchers, specify the risks and
possible accidents, and emphasize that sample providers
have the right to terminate the informed consent at any
time. In addition, it is also necessary to set up provisions
to restrict researchers, including the qualification level of
the personnel in biobanks and the supervision contents
for the supervision department, so as to ensure
that biological samples are only used for medical
research and are destroyed and processed after the
research is completed, and ensure that the personal
information and privacy of sample providers will not be
disclosed. This is not only conducive to the protection of
the rights and interests of sample providers, but also can
improve the participation of sample providers, as well as
protect the researchers. On the basis of full
understanding and acceptance of the contents of the
informed consent, sample researchers independently
choose to sign it and are authorized to use the biological
samples and related information under the review of the
ethics committee[6,7].
5. Conclusion
This article analyzes the establishment, operation
and management of clinical biobanks, then briefly
expounds the medical ethics faced by the research of
clinical biobanks, and finally summarizes the key points
of ethical review. In general, to establish, operate and
manage biobanks, it is necessary to set up the
requirements of collection and induction, classification,
data collation, security, and so on, improve the control
and management system, and give effective protection
to biological samples and their information. With the
continuous in-depth work, a system of resource
development and utilization of biological samples
has been gradually established to provide help,
cooperation and mutual assistance for subsequent
medical research, and finally the sharing of biological
samples can be realized, thus promoting the sustainable
development of biobanks[8].
Acknowledgement
This article is supported by the fund of Affiliated
Hospital of Hebei University (No. 2019Q001).
References
1. Guo Y. Clinical biobank (in Chinese). Beijing:
Science Press; 2014. p. 260.
2. Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM.
48 | Meng Yu et al. Advanced Emergency Medicine
Trends in ethical and legal frameworks for the use
of human biobanks. European Respiratory Journal
2007; 30(2): 373-382. doi:
10.1183/09031936.00165006.
3. Pawlikowski J, Sak J, Marczewski K. Special
report biobank research and ethics: The problem of
informed consent in polish biobanks. Archives of
Medical Science 2011; 7(5): 896-901. doi:
10.5114/aoms.2011.25568.
4. Liu M. Introduction to biobank and ethics (in
Chinese). Chinese Bulletin of Life Sciences 2012;
24(11): 1318-1324.
5. Zhu S, Shen M, Qiu X, et al. Ethical management
guidelines for the Shanghai disease-based biobank
network. Biopreservation & Biobanking 2015;
13(1): 8-12. doi: 10.1089/bio.2014.0087.
6. Kaufman D, Bollinger J, Dvoskin R, et al.
Preferences for opt-in and opt-out enrollment and
consent models in biobank research: A national
survey of Veterans Administration patients.
Genetics in Medicine 2012; 14(9): 787-794. doi:
10.1038/gim.2012.45.
7. Li H, Liang Z, Zeng L, et al. Ethical issues
caused by informed consent signing in the research
of bioinformatics database (in Chinese). World
Science and Technology 2013; 15(4): 729-734.
8. Xiong N, Liu H, Li Y, et al. Guidelines for ethical
review of biomedical research involving humans.
Beijing: Science Press; 2014. p. 157.
